Published in

European Respiratory Society, European Respiratory Journal, 6(43), p. 1621-1630

DOI: 10.1183/09031936.00151513

Links

Tools

Export citation

Search in Google Scholar

Does exercise test modality influence dyspnoea perception in obese patients with COPD?

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The purpose of this study was to investigate whether differences in physiological responses to weight-bearing (walking) and weight-supported (cycle) exercise influence dyspnoea perception in obese COPD patients where such discrepancies are likely exaggerated.We compared metabolic, ventilatory and perceptual responses during incremental treadmill and cycle exercise using a matched linearized rise in work rate in 18 (10 males, 8 females) obese (body mass index 36.4±5.0 kg·m(-2); mean±SD) patients with COPD (FEV1 60±11% predicted).Compared with cycle testing, treadmill testing was associated with a significantly higher oxygen uptake, lower ventilatory equivalent for oxygen, and greater oxyhemoglobin desaturation at a given work rate (p<0.01). Cycle testing was associated with a higher respiratory exchange ratio (p<0.01), earlier ventilatory threshold (p<0.01) and greater peak leg discomfort ratings (p=0.01). Ventilation, breathing pattern and operating lung volumes were similar between tests, as were dyspnoea/work rate and dyspnoea/ventilation relations.Despite significant between-test differences in physiological responses, ventilation, operating lung volumes and dyspnoea intensity were similar at any given external power output during incremental walking and cycling exercise in obese COPD patients. These data provide evidence that either exercise modality can be selected for reliable evaluation of exertional dyspnoea in this population in research and clinical settings.